Motion-aware radiation therapy sharpens cancer targeting in dogs
CURRENT BRIEF VERSION: A collaboration between the University of Illinois College of Veterinary Medicine and Washington University in St. Louis is testing motion-aware radiation therapy for dogs with cancers in or near the chest, where breathing can shift tumors during treatment. The project uses respiratory gated cone-beam CT, a four-dimensional imaging approach that captures tumor motion through the breathing cycle, then applies motion-compensated reconstruction algorithms to sharpen images and improve positioning before radiation is delivered. According to the Cancer Center at Illinois, the team has scanned 10 dogs so far, and a model originally trained on human data successfully reconstructed the canine scans. The work was presented at the 2025 American Association of Physicists in Medicine annual meeting, where it received a Blue-Ribbon Poster Award for Excellence in Research. (eurekalert.org)
Why it matters: For veterinary professionals, this is a practical example of comparative oncology moving into treatment delivery, not just drug development. Motion management could help radiation oncologists use tighter treatment margins for thoracic and perithoracic tumors, potentially reducing dose to nearby healthy tissue and lowering the risk of long-term complications. That matters in veterinary settings where balancing efficacy, toxicity, repeated anesthesia, travel, and cost is central to case planning and conversations with pet parents. Radiation therapy in dogs typically relies on CT-based planning and multiple anesthetized treatment fractions, so any workflow that improves precision may have real value for both case selection and owner decision-making. The Illinois team also said grant funding helped cover advanced CT imaging in the study, improving access for participating families. (eurekalert.org; petmd.com)
What to watch: Watch for larger canine datasets, peer-reviewed publication of outcomes, and whether motion-aware workflows begin to influence how specialty centers plan radiation for moving thoracic tumors, including whether they support more precise hypofractionated or stereotactic-style approaches in appropriate cases. (eurekalert.org; petmd.com)